Trial Profile

CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 MICROGRAM/GRAM WITH THREE CONCENTRATIONS (100, 250, 500 MICROGRAM/GRAM) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ PSORIASIS MINI PLAQUE TEST UNDER NON-OCCLUSIVE CONDITIONS.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Calcitriol/clobetasol (Primary) ; Betamethasone-dipropionate/calcipotriol; Clobetasol
Indications Plaque psoriasis
Focus First in man; Therapeutic Use

31 Mar 2022 Status changed from recruiting to completed (Date of the global end of the trial 14 May 2007)
12 Jul 2011 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com